AU4754790A - Therapeutic use of dihydropyrimidones and benzazepine and benzothiazepine derivatives in retinal or optic nerve dysfunction - Google Patents

Therapeutic use of dihydropyrimidones and benzazepine and benzothiazepine derivatives in retinal or optic nerve dysfunction

Info

Publication number
AU4754790A
AU4754790A AU47547/90A AU4754790A AU4754790A AU 4754790 A AU4754790 A AU 4754790A AU 47547/90 A AU47547/90 A AU 47547/90A AU 4754790 A AU4754790 A AU 4754790A AU 4754790 A AU4754790 A AU 4754790A
Authority
AU
Australia
Prior art keywords
dihydropyrimidones
benzazepine
retinal
therapeutic use
optic nerve
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU47547/90A
Inventor
Gunner Aberg
Craig E. Crosson
David Floyd
Miguel A. Ondetti
David E. Potter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Houston Biotechnology Inc
ER Squibb and Sons LLC
Original Assignee
Houston Biotechnology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Houston Biotechnology Inc filed Critical Houston Biotechnology Inc
Publication of AU4754790A publication Critical patent/AU4754790A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU47547/90A 1988-12-05 1989-12-05 Therapeutic use of dihydropyrimidones and benzazepine and benzothiazepine derivatives in retinal or optic nerve dysfunction Abandoned AU4754790A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27953788A 1988-12-05 1988-12-05
US279537 1988-12-05

Publications (1)

Publication Number Publication Date
AU4754790A true AU4754790A (en) 1990-06-26

Family

ID=23069415

Family Applications (2)

Application Number Title Priority Date Filing Date
AU48077/90A Abandoned AU4807790A (en) 1988-12-05 1989-12-05 Therapeutic use of calcium entry blockers in retinal or optic nerve dysfunction
AU47547/90A Abandoned AU4754790A (en) 1988-12-05 1989-12-05 Therapeutic use of dihydropyrimidones and benzazepine and benzothiazepine derivatives in retinal or optic nerve dysfunction

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU48077/90A Abandoned AU4807790A (en) 1988-12-05 1989-12-05 Therapeutic use of calcium entry blockers in retinal or optic nerve dysfunction

Country Status (3)

Country Link
AU (2) AU4807790A (en)
CA (2) CA2004616A1 (en)
WO (2) WO1990006123A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5525601A (en) * 1990-09-07 1996-06-11 Universidad De Alicante Composition for treating ocular pain
ATE129890T1 (en) * 1990-09-07 1995-11-15 Univ Alicante COMPOSITION FOR THE TREATMENT OF EYE PAIN.
CA2277965A1 (en) * 1997-02-04 1998-08-06 Marc A. Bruce Dihydropyrimidone derivatives as npy antagonists
DE19718826A1 (en) * 1997-05-05 1998-11-12 Marion S Dr Eckmiller Use of biologically active agents to influence the extracellular space of sensory cells and methods for drug administration control
US6037354A (en) * 1997-06-18 2000-03-14 Merck & Co., Inc. Alpha 1a adrenergic receptor antagonists
AU727080B2 (en) 1997-06-30 2000-11-30 Allergan, Inc. Calcium blockers to treat proliferative vitreoretinopathy
WO1999025350A1 (en) * 1997-11-14 1999-05-27 Alcon Laboratories, Inc. Treatment of diabetic retinopathy
EP1051973B1 (en) * 1998-01-29 2004-07-14 Akzo Nobel N.V. Optic papillary circulation improving agents
FR2784030B1 (en) * 1998-10-02 2002-12-20 Inst Nat Sante Rech Med USE OF CALCIUM AND / OR CGMP-DEPENDENT CHANNEL BLOCKERS FOR THE TREATMENT OF RETINE CONDITIONS
WO2000020002A1 (en) * 1998-10-02 2000-04-13 Sucampo, A.G. Composition for treatment of light-injured retinal degeneration disease
US8557855B2 (en) * 2002-07-03 2013-10-15 Allergan, Inc. Methods of using ryanodine antagonists in treating neural injury
US10111873B1 (en) 2018-01-17 2018-10-30 King Saud University Dihydropyrimidinone derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4694002A (en) * 1986-08-21 1987-09-15 E. R. Squibb & Sons, Inc. Benzothiazepine derivatives

Also Published As

Publication number Publication date
AU4807790A (en) 1990-06-26
WO1990006123A1 (en) 1990-06-14
CA2004617A1 (en) 1990-06-05
WO1990006118A1 (en) 1990-06-14
CA2004616A1 (en) 1990-06-05

Similar Documents

Publication Publication Date Title
AU4467589A (en) Treatment of skin diseases with artemisinin and derivatives
AU649605B2 (en) Retinal, derivatives and their therapeutic use
PL330235A1 (en) Derivatives of spiropiperidine and their application as therapeutic agents
AU7605396A (en) Cannula with associated filter and methods of use during cardiac surgery
EP0333344A3 (en) Corneal implants and manufacture and use thereof
GB9613003D0 (en) N-oxides of morpholine derivatives and their use as therapeutic agents
AU6566094A (en) Heterocyclic derivatives in the treatment of ischaemia and related diseases
AU4658489A (en) Use of acetyl d-carnitine in the therapeutic treatment of glaucoma
AU6813694A (en) Use of green porphyrins in ocular diagnosis and therapy
AU4754790A (en) Therapeutic use of dihydropyrimidones and benzazepine and benzothiazepine derivatives in retinal or optic nerve dysfunction
YU121389A (en) Derivatives of benzazepine and benzothiazepine
HUP9900186A3 (en) Use of lamellarin alkaloids in therapy and pharmaceutical compositions containing them
GB9103075D0 (en) Trinitrobenzene derivatives and their therapeutic use
AU2807689A (en) Method for the treatment of body tissues and the administration of drugs thereto
PL321741A1 (en) Bicyclic derivatives of isothiourea useful in medical therapy
AU3028589A (en) Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments for the treatment of cardiac arrhythmia
EP0393180A4 (en) 26-aminocholesterol and derivatives and analogs thereof in the regulation of cholesterol accumulation in body tissue
ZA898741B (en) Use of azepinone derivatives
IL107726A0 (en) Pyrrole derivatives their preparation and their therapeutic use
AU4096789A (en) The use of lactam derivatives in the treatment of cognitive disorders
AU2623088A (en) New anti-receptor peptides and therapeutic agents
AU4319393A (en) Use of indolocarbazols in aids treatment
AU4096689A (en) The use of lactam derivatives in the treatment of addiction
AU631408B2 (en) Benzazepine and benzothiazepine derivatives
AU641157B2 (en) 2-imino-thiadiazoline-5-sulphonamides and their use in the treatment of glaucoma